Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin versus gliclazide for renal physiology in metformin-treated type 2 diabetes
2015-003818-24Phase 4Active
- Sponsor
- VU University Medical Center
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Dapagliflozin arm with Gliclazide arm (2 arms). Primary endpoint: Glomerular filtration rate. Started Nov 2015; status: active.
02
Drugs
dapagliflozingliclazide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2015-003818-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003818-24.